Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial
Taylan Gurgenci, Janet Hardy, Georgie Huggett, K. Foster, Anita Pelecanos, Ristan M Greer, J. Philip, Alison Haywood, R. Mendis, Patsy Yates, Phillip Good
Trials